杂志简称：biotechnol lett
中文译名：《生物技术快报》
收录属性：scie（2024版）, 目次收录（维普）, 目次收录（知网）,英文期刊,
自引率：4.80%
投稿方向：工程技术、biotechnology & applied microbiology生物工程与应用微生物
SCI/E期刊基本信息
出版周期：月刊 地区：荷兰
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 0141-5492；EISSN 1573-6776
杂志语言：英语
出版国家：荷兰
杂志官网 联系方式
出版地址：VAN GODEWIJCKSTRAAT 30,DORDRECHT,NETHERLANDS,3311 GZ
杂志邮箱：
投稿网址：https://www.editorialmanager.com/bile/
杂志官方网址：https://www.springer.com/journal/10529/
出版商网址：http://www.springeronline.com
杂志投稿要求
投稿须知【杂志社官方网站信息】
Biotechnology Letters
Submission guidelines
Instructions for Authors
Editorial procedure
Biotechnology Letters is a rapid-publication journal that is dedicated to biotechnology as a whole – that is to topics relating to actual or potential applications of biological reactions affected by microbial, plant or animal cells and biocatalysts derived from them. All relevant aspects of molecular biology, genetics and cell biochemistry, synthetic biology and molecular engineering, of bioprocessing and biological engineering including tissue engineering and biotechnological aspects of regenerative medicine, of pre- and post-treatment steps, and of manufacturing or service operations are therefore included. Contributions from industrial and academic laboratories are equally welcome.
Before submitting their manuscripts to the journal, authors are asked to check the relevancy of their work for publication by reading the Aims and Scope that are printed in each issue of the journal and are also available from our website. To ensure relevancy, authors should also check if citations of relevant papers previously published in this journal are included in their submitted paper.
Prepare your error-free manuscript as an e-mail attachment in Word or Wordperfect (not Mac). A covering letter indicating the novelty, urgency or timeliness of your communication will be appreciated.
Please do not forget to indicate the section (please see “Types of Papers”) your paper belongs to on the title page.
Further advice on page limits and how papers should be structured and written is given in our Guidance Notes for Authors.
Guidance Notes for Authors (Download pdf, 392 kB)
Plagiarism prevention with CrossCheck
Springer is a participant of CrossCheck, a multi-publisher plagiarism detection initiative to screen published and submitted content for originality. CrossCheck consists of two products: a database of scholarly publications (CrossCheck) and a web-based tool (iThenticate) to check an authored work against that database.
This journal uses the plagiarism tool to detect instances of overlapping and similar text in submitted manuscripts and your manuscript may be screened upon submission for plagiarism against previously published works.
Authorship Policy
Authorship should incorporate and should be restricted to those who have contributed substantially to the work in one or more of the following categories:
• Conceived of or designed study
• Performed research
• Analyzed data
• Contributed new methods or models
• Wrote the paper
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
…